Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Semjonow

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
The Journal of Urology|April 18, 2007
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosisSusan Cottrell, Klaus Jung, Glen Kristiansen, et al.
Anticancer Research|July 2, 2010
Proposal for a standardized PSA doubling-time calculationAnton Ponholzer, Nikolaus Popper, Felix Breitenecker, et al.
European Urology Oncology|May 18, 2019
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter StudyAndrew M Erickson, Stefano Luzzago, Axel Semjonow, et al.
Clinical Chemistry|December 6, 2012
Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancerCarsten Stephan, Klaus Jung, Axel Semjonow, et al.
Clinical Chemistry|July 27, 2002
Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsiesCarsten Stephan, Henning Cammann, Axel Semjonow, et al.
European Urology|December 13, 2002
Combining free and total prostate specific antigen assays from different manufacturers: the pitfallsFrank Oberpenning, Christoph Weining, Burkhard Brandt, et al.
Clinical Chemistry and Laboratory Medicine|March 15, 2003
A new modification of the Chiron ACS assay for total prostate-specific antigen achieves equimolar response characteristics and improves the detection of prostate cancerFrank Oberpenning, Christoph Weining, Burkhard Brandt, et al.
Electrophoresis|June 28, 2005
Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urineDan Theodorescu, Danilo Fliser, Stefan Wittke, et al.
International Journal of Molecular Sciences|February 14, 2015
Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients with PSA recurrence after radical prostatectomyChinyere Ibeawuchi, Hartmut Schmidt, Reinhard Voss, et al.
The Journal of Urology|November 11, 2005
A multicenter clinical trial on the use of (-5, -7) pro prostate specific antigenMichael Lein, Axel Semjonow, Markus Graefen, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Urology|April 18, 2007
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosisSusan Cottrell, Klaus Jung, Glen Kristiansen, et al.
Anticancer Research|July 2, 2010
Proposal for a standardized PSA doubling-time calculationAnton Ponholzer, Nikolaus Popper, Felix Breitenecker, et al.
European Urology Oncology|May 18, 2019
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter StudyAndrew M Erickson, Stefano Luzzago, Axel Semjonow, et al.
Clinical Chemistry|December 6, 2012
Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancerCarsten Stephan, Klaus Jung, Axel Semjonow, et al.
Clinical Chemistry|July 27, 2002
Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsiesCarsten Stephan, Henning Cammann, Axel Semjonow, et al.
European Urology|December 13, 2002
Combining free and total prostate specific antigen assays from different manufacturers: the pitfallsFrank Oberpenning, Christoph Weining, Burkhard Brandt, et al.
Clinical Chemistry and Laboratory Medicine|March 15, 2003
A new modification of the Chiron ACS assay for total prostate-specific antigen achieves equimolar response characteristics and improves the detection of prostate cancerFrank Oberpenning, Christoph Weining, Burkhard Brandt, et al.
Electrophoresis|June 28, 2005
Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urineDan Theodorescu, Danilo Fliser, Stefan Wittke, et al.
International Journal of Molecular Sciences|February 14, 2015
Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients with PSA recurrence after radical prostatectomyChinyere Ibeawuchi, Hartmut Schmidt, Reinhard Voss, et al.
The Journal of Urology|November 11, 2005
A multicenter clinical trial on the use of (-5, -7) pro prostate specific antigenMichael Lein, Axel Semjonow, Markus Graefen, et al.
Pageof 11